# US 2017/0283359 A1 · Process for large scale production of 1-isopropyl-3--1h-indazole oxalate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283359 A1
- Document ID: US20170283359A1
- Status: Published application
- Kind: A1
- Application number: 15/504,224
- Filed: 2014-10-23
- Published: 2017-10-05
- Earliest claimed: 2014-08-16
- Assignees: Suven Life Sciences Limited
- Applicants: Suven Life Sciences Limited
- Inventors: Ramakrishna NIROGI; Abdul Rasheed MOHAMMED; Venkateswarlu JASTI
- Web page: https://patentgrep.com/patent/US20170283359A1

## CPC

- C07C 51/412: {by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part}
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C07C 51/43: by change of the physical state, e.g. crystallisation
- C07C 55/07: Salts thereof
- C07D 413/14: containing three or more hetero rings
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention relates to a process suitable for adoption to large scale manufacture of 1-isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole oxalate of formula (I), which is a selective 5-HT4 receptor ligand intended for the symptomatic treatment of Alzheimer's disease and other disorders of memory and cognition like Attention deficient hyperactivity, Parkinson's and Schizophrenia.

## Claims

### Claim 1

A process for large scale production of 1-Isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole oxalate of formula (I),
the process comprising the steps of:
Step (i): coupling of 1-(3-Methoxypropyl) piperidine-4-carboxylic acid hydrazide of formula 1 with 1-Isopropyl-1H-indazole-3-carbonyl chloride of formula 2
in presence of dichloroethane at a temperature in the range of 20° C. to 35° C. for a period of 1.5 hours to 2.5 hours to obtain N-[1-(3-Methoxypropyl) piperidine-4-carbonyl] N′-(1-isopropyl-1H-indazole-3-carbonyl) hydrazine of formula 3;
Step (ii): cyclizing N-[1-(3-Methoxypropyl) piperidine-4-carbonyl] N′-(1-isopropyl-1H-indazole-3-carbonyl) hydrazine of formula 3 in presence of thionyl chloride in solvent selected from dichloromethane, 1,2-dichloroethane and chlorobenzene at a temperature in the range of 60° C. to 95° C. for a period of 8 hours to 10 hours to obtain 1-isopropyl-3-{5-[1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole of formula 4;
Step (iii): purifying 1-isopropyl-3-{5-[1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole of formula 4 using mixture of acetic acid and water at a temperature in the range of 20° C. to 35° C.;
Step (iv): reacting 1-isopropyl-3-{5-[1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole of formula 4 with oxalic acid in presence of isopropanol at a temperature in the range of 20° C. to 35° C. for a period of 1 hour to 4 hours to obtain 1-Isopropyl-3-{5-[1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole oxalate of formula (I);
Step (v): recrystallizing compound of formula (I) using a mixture of isopropanol and water at a temperature range of 70° C. to 80° C. for a period of 15 hours to 17 hours.

### Claim 2 (depends on 1)

The process as claimed in claim 1, wherein the temperature used in Step (i) is 25° C. to 30° C.

### Claim 3 (depends on 1)

The process as claimed in claim 1, wherein the duration of reaction in Step (i) is 2 hours.

### Claim 4 (depends on 1)

The process as claimed in claim 1, wherein the temperature used in Step (ii) is 70° C. to 85° C.

### Claim 5 (depends on 1)

The process as claimed in claim 1, wherein the duration of reaction in Step (ii) is 9 hours.

### Claim 6 (depends on 1)

The process as claimed in claim 1, wherein the ratio of acetic acid and water in Step (iii) is 1:9.

### Claim 7 (depends on 1)

The process as claimed in claim 1, wherein the temperature used in Step (iii) is 25° C. to 30° C.

### Claim 8 (depends on 1)

The process as claimed in claim 1, wherein the temperature used in Step (iv) is 25° C. to 30° C.

### Claim 9 (depends on 1)

The process as claimed in claim 1, wherein the duration of reaction in Step (iv) is 2 hours.

### Claim 10 (depends on 1)

The process as claimed in claim 1, wherein the temperature used in Step (v) is 74° C. to 78° C.

### Claim 11 (depends on 1)

The process as claimed in claim 1, wherein the duration of reaction in Step (v) is 16 hours.

### Claim 12 (depends on 1)

The process as claimed in claim 1, wherein the ratio of isopropanol and water in Step (v) is 5:1.

### Claim 13 (depends on 1)

The process as claimed in claim 1, wherein the purity of 1-Isopropyl-3-{5-[1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole oxalate of formula (I) is >99.9% pure.

### Claim 14

(canceled)

### Claim 15

A process for preparation of compound of formula 3, wherein the process comprises the step of reacting 1-isopropyl-1H-indazole-3-carboxylic acid with thionyl chloride to obtain 1-isopropyl-1H-indazole-3-carbonyl chloride which without isolation on further reaction with 1-(3-methoxypropyl) piperidine-4-carboxylic acid in dichloromethane at the temperature range of 20° C. to 30° C. for a period of 1 hour to 3 hours to obtain the compound of formula 3,

### Claim 16 (depends on 15)

The process as claimed in claim 15, wherein the process for the preparation of 1-isopropyl-1H-indazole-3-carboxylic acid comprises the step of, reacting the indazole-3-carboxylic acid with isopropyl iodide in presence of sodium tert-butoxide and dimethylformamide at the temperature range of 25° C. to 30° C. for a period of 16 hours to 18 hours.

### Claim 17

An intermediate compound of formula 3,
